Literature DB >> 10770437

Sebaceous neoplasms in Muir-Torre syndrome.

N Misago1, Y Narisawa.   

Abstract

A 59-year-old Japanese woman presented with two sebaceous neoplasms on the chest wall and on the left cheek. The patient had a history of ascending colon cancer, and her mother had died of gastric cancer. The histopathologic features of both sebaceous neoplasms were vaguely in accordance with those of sebaceous adenoma and sebaceoma. Based on these findings, we diagnosed the patient as having Muir-Torre syndrome. The sebaceous neoplasm on the chest wall exhibited features of a sebaceous adenoma with a unique cystic appearance, namely cystic sebaceous adenoma, which has been reported as a specific marker for Muir-Torre syndrome (MTS). However, histopathologically, both the sebaceous adenoma and sebaceoma had relatively large, vesicular or heterochromous and crowded nuclei with some pleomorphism and distinct nucleoli associated with some mitotic figures, casting doubt on their benignancy. We show that some or most benign sebaceous neoplasms in MTS might have a high potential for malignant transformation or may be well-differentiated sebaceous carcinomas with low-grade malignancy, mimicking sebaceous adenoma/sebaceoma. This results in difficulties in classification regarding sebaceous neoplasms in MTS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10770437     DOI: 10.1097/00000372-200004000-00012

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  3 in total

1.  Development of seven secondary neoplasms in a nevus sebaceous: a case report and literature review.

Authors:  Yi-Wen Kuo; Jung-Chia Lin; Wei-Hsuan Tsai
Journal:  Arch Craniofac Surg       Date:  2022-03-30

2.  Sebaceous neoplasia and Torre-Muir syndrome.

Authors:  A J F Lazar; S Lyle; E Calonje
Journal:  Curr Diagn Pathol       Date:  2007-08

Review 3.  [Differential diagnostics of sebaceous tumors].

Authors:  A Böer-Auer
Journal:  Pathologe       Date:  2014-09       Impact factor: 1.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.